Search research articles
Contact Us
Filters
Showing results (881-890 of 1,066) with videos related to
Page
of 107
Sort By:
Nature Genetics
|
February 22, 2005
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
Li Yu, Chunhui Liu, Jeff Vandeusen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621
Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma
Khuda D Khan, Christos Emmanouilides, Don M Benson, et al.
Immunity
|
May 23, 2006
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells
Jianhua Yu, Min Wei, Brian Becknell, et al.
Journal of Medicinal Chemistry
|
May 6, 2022
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
Giulia Bononi, Miriana Di Stefano, Giulio Poli, et al.
European Journal of Medicinal Chemistry
|
August 26, 2018
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors
Giulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.
The Journal of Clinical Investigation
|
September 19, 2006
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations
Adrienne M Dorrance, Shujun Liu, Weifeng Yuan, et al.
Blood
|
August 12, 2006
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics
Daniel J DeAngelo, Richard M Stone, Mark L Heaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
James P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.
Blood
|
December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
Farrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Page
of 107
Search research articles
Search
Showing results (881-890 of 1,066) with videos related to
Sort By:
Page
of 107
Nature Genetics
|
February 22, 2005
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
Li Yu, Chunhui Liu, Jeff Vandeusen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621
Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma
Khuda D Khan, Christos Emmanouilides, Don M Benson, et al.
Immunity
|
May 23, 2006
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells
Jianhua Yu, Min Wei, Brian Becknell, et al.
Journal of Medicinal Chemistry
|
May 6, 2022
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
Giulia Bononi, Miriana Di Stefano, Giulio Poli, et al.
European Journal of Medicinal Chemistry
|
August 26, 2018
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors
Giulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.
The Journal of Clinical Investigation
|
September 19, 2006
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations
Adrienne M Dorrance, Shujun Liu, Weifeng Yuan, et al.
Blood
|
August 12, 2006
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics
Daniel J DeAngelo, Richard M Stone, Mark L Heaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
James P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.
Blood
|
December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
Farrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Page
of 107